FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats

Takahiro Sasaki, Junichi Hamada, Mamoru Shibata, Jun Gotoh, Nobuo Araki, Yasuo Fukuuchi

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and purpose: The mechanism of the neuroprotective effect of FK506 in relation to nitric oxide (NO) production has not been clarified in vivo. We have investigated the effect of FK506 on ischemia-induced NO production in association with the pathogenesis of delayed neuronal death (DND) in rats. Methods: In vivo microdialysis was performed in the hippocampus of male Sprague-Dawley rats (250-350 g). Dialysate samples were collected every 3 min. In the ischemia group (n=16), global ischemia was induced for 21 min and reperfusion was achieved. In the FK506 treatment group (n=25), FK506 (1 mg/kg, i.v.) was administered 21 min prior to the onset of global ischemia. Sham operations were done (n=15). The levels of NO2- in the dialysate samples were determined by the Griess reaction. The animals were decapitated 7 days after ischemia. Coronal brain sections were stained with hematoxylin and eosin. Results: In the ischemia group, the NO2 - level significantly increased during ischemia. In the FK506 treatment group, there was no significant change in the NO2 - level during ischemia. In histological examinations, FK506 treatment showed a neuroprotective effect against DND. Conclusions: The effect of FK506 inhibiting NO production contributes to the neuro-protective effect of FK506 on DND in the hippocampus.

Original languageEnglish
Pages (from-to)34-39
Number of pages6
JournalBrain Research
Volume1009
Issue number1-2
DOIs
Publication statusPublished - 2004 May 29

Fingerprint

Tacrolimus
Nitric Oxide
Ischemia
Dialysis Solutions
Neuroprotective Agents
Hippocampus
Microdialysis
Hematoxylin
Eosine Yellowish-(YS)
Reperfusion
Sprague Dawley Rats
Brain

Keywords

  • Cerebral ischemia
  • Disorders of the nervous system
  • Global
  • Hippocampus
  • Ischemia
  • Microdialysis
  • Nitric oxide
  • Rat

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats. / Sasaki, Takahiro; Hamada, Junichi; Shibata, Mamoru; Gotoh, Jun; Araki, Nobuo; Fukuuchi, Yasuo.

In: Brain Research, Vol. 1009, No. 1-2, 29.05.2004, p. 34-39.

Research output: Contribution to journalArticle

Sasaki, Takahiro ; Hamada, Junichi ; Shibata, Mamoru ; Gotoh, Jun ; Araki, Nobuo ; Fukuuchi, Yasuo. / FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats. In: Brain Research. 2004 ; Vol. 1009, No. 1-2. pp. 34-39.
@article{b6b4d300ae5d49adaad90a64ba5b998f,
title = "FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats",
abstract = "Background and purpose: The mechanism of the neuroprotective effect of FK506 in relation to nitric oxide (NO) production has not been clarified in vivo. We have investigated the effect of FK506 on ischemia-induced NO production in association with the pathogenesis of delayed neuronal death (DND) in rats. Methods: In vivo microdialysis was performed in the hippocampus of male Sprague-Dawley rats (250-350 g). Dialysate samples were collected every 3 min. In the ischemia group (n=16), global ischemia was induced for 21 min and reperfusion was achieved. In the FK506 treatment group (n=25), FK506 (1 mg/kg, i.v.) was administered 21 min prior to the onset of global ischemia. Sham operations were done (n=15). The levels of NO2- in the dialysate samples were determined by the Griess reaction. The animals were decapitated 7 days after ischemia. Coronal brain sections were stained with hematoxylin and eosin. Results: In the ischemia group, the NO2 - level significantly increased during ischemia. In the FK506 treatment group, there was no significant change in the NO2 - level during ischemia. In histological examinations, FK506 treatment showed a neuroprotective effect against DND. Conclusions: The effect of FK506 inhibiting NO production contributes to the neuro-protective effect of FK506 on DND in the hippocampus.",
keywords = "Cerebral ischemia, Disorders of the nervous system, Global, Hippocampus, Ischemia, Microdialysis, Nitric oxide, Rat",
author = "Takahiro Sasaki and Junichi Hamada and Mamoru Shibata and Jun Gotoh and Nobuo Araki and Yasuo Fukuuchi",
year = "2004",
month = "5",
day = "29",
doi = "10.1016/j.brainres.2004.01.088",
language = "English",
volume = "1009",
pages = "34--39",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - FK506 abrogates delayed neuronal death via suppression of nitric oxide production in rats

AU - Sasaki, Takahiro

AU - Hamada, Junichi

AU - Shibata, Mamoru

AU - Gotoh, Jun

AU - Araki, Nobuo

AU - Fukuuchi, Yasuo

PY - 2004/5/29

Y1 - 2004/5/29

N2 - Background and purpose: The mechanism of the neuroprotective effect of FK506 in relation to nitric oxide (NO) production has not been clarified in vivo. We have investigated the effect of FK506 on ischemia-induced NO production in association with the pathogenesis of delayed neuronal death (DND) in rats. Methods: In vivo microdialysis was performed in the hippocampus of male Sprague-Dawley rats (250-350 g). Dialysate samples were collected every 3 min. In the ischemia group (n=16), global ischemia was induced for 21 min and reperfusion was achieved. In the FK506 treatment group (n=25), FK506 (1 mg/kg, i.v.) was administered 21 min prior to the onset of global ischemia. Sham operations were done (n=15). The levels of NO2- in the dialysate samples were determined by the Griess reaction. The animals were decapitated 7 days after ischemia. Coronal brain sections were stained with hematoxylin and eosin. Results: In the ischemia group, the NO2 - level significantly increased during ischemia. In the FK506 treatment group, there was no significant change in the NO2 - level during ischemia. In histological examinations, FK506 treatment showed a neuroprotective effect against DND. Conclusions: The effect of FK506 inhibiting NO production contributes to the neuro-protective effect of FK506 on DND in the hippocampus.

AB - Background and purpose: The mechanism of the neuroprotective effect of FK506 in relation to nitric oxide (NO) production has not been clarified in vivo. We have investigated the effect of FK506 on ischemia-induced NO production in association with the pathogenesis of delayed neuronal death (DND) in rats. Methods: In vivo microdialysis was performed in the hippocampus of male Sprague-Dawley rats (250-350 g). Dialysate samples were collected every 3 min. In the ischemia group (n=16), global ischemia was induced for 21 min and reperfusion was achieved. In the FK506 treatment group (n=25), FK506 (1 mg/kg, i.v.) was administered 21 min prior to the onset of global ischemia. Sham operations were done (n=15). The levels of NO2- in the dialysate samples were determined by the Griess reaction. The animals were decapitated 7 days after ischemia. Coronal brain sections were stained with hematoxylin and eosin. Results: In the ischemia group, the NO2 - level significantly increased during ischemia. In the FK506 treatment group, there was no significant change in the NO2 - level during ischemia. In histological examinations, FK506 treatment showed a neuroprotective effect against DND. Conclusions: The effect of FK506 inhibiting NO production contributes to the neuro-protective effect of FK506 on DND in the hippocampus.

KW - Cerebral ischemia

KW - Disorders of the nervous system

KW - Global

KW - Hippocampus

KW - Ischemia

KW - Microdialysis

KW - Nitric oxide

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=2142715917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142715917&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2004.01.088

DO - 10.1016/j.brainres.2004.01.088

M3 - Article

C2 - 15120581

AN - SCOPUS:2142715917

VL - 1009

SP - 34

EP - 39

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1-2

ER -